Palmatine from Mahonia bealei attenuates gut tumorigenesis in ApcMin/+ mice via inhibition of inflammatory cytokines

Ma,Wei‑Kun; Li,Hui; Dong,Cui‑Lan; He,Xin; Guo,Chang‑Run; Zhang,Chun‑Feng; Yu,Chun‑Hao; Wang,Chong‑Zhi; Yuan,Chun‑Su

doi:10.3892/mmr.2016.5285

Palmatine from Mahonia bealei attenuates gut tumorigenesis in ApcMin/+ mice via inhibition of inflammatory cytokines

Authors:
- Wei‑Kun Ma
- Hui Li
- Cui‑Lan Dong
- Xin He
- Chang‑Run Guo
- Chun‑Feng Zhang
- Chun‑Hao Yu
- Chong‑Zhi Wang
- Chun‑Su Yuan
View Affiliations

Affiliations: Teaching and Research Section of Traditional Chinese Pharmaceutics, China Pharmaceutical University, Nanjing, Jiangsu 210009, P.R. China, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu 210009, P.R. China, Department of Traditional Chinese Medicine, People's Hospital of Zhangqiu, Zhangqiu, Jinan, Shandong 250200, P.R. China, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210000, P.R. China, Tang Center of Herbal Medicine Research and Department of Anesthesia and Critical Care, University of Chicago, Chicago, IL 60637, USA
Published online on: May 13, 2016 https://doi.org/10.3892/mmr.2016.5285
Pages: 491-498

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Mahonia bealei is a Chinese folk medicine used to treat various ailments, in particular gastrointestinal inflammation‑related illnesses, and palmatine is one of its active constituents. In this study, ApcMin/+ mice, a genetically engineered model, were used to investigate the effects of palmatine on the initiation and progression of gut inflammation and tumorigenesis enhanced by a high‑fat diet. The in vitro antiproliferation and anti‑inflammation effects of palmatine were evaluated on HT‑29 and SW‑480 human colorectal cancer cell lines. The concentration‑related antiproliferative effects of palmatine on both cell lines (P<0.01) were observed. Palmatine significantly inhibited lipopolysaccharide‑induced increase in cytokine interleukin (IL)‑8 levels in the HT‑29 cells (P<0.01). In the in vivo studies with ApcMin/+ mice, after 10 or 20 mg/kg/day oral palmatine treatment, tumor numbers were significantly reduced in the small intestine and colon in a dose‑dependent manner (P<0.01 compared with the model group). The results were supported by tumor distribution data, body weight changes and organ index. The effect on survival was also dose‑dependent. Both the low‑ and high‑dose palmatine treatments significantly increased the life span of the mice (P<0.01). The gut histology from the model group showed a prominent adenomatous change along with inflammatory lesions. With palmatine treatment, however, the dysplastic changes were greatly reduced in the small intestine and colon tissue. Reverse transcription‑quantitative polymerase chain reaction analysis of interleukin (IL)‑1α, IL1‑β, IL‑8, granulocyte‑colony stimulating factor and granulocyte macrophage colony‑stimulating factor in the gut tissue showed that these inflammatory cytokines were reduced significantly following treatment (all P<0.01); serum cytokine levels were also decreased. Data suggests that palmatine has a clinical value in colorectal cancer therapeutics, and this action is likely linked to the inhibition of inflammatory cytokines.

View Figures

View References

1	Siegel R, Desantis C and Jemal A: Colorectal cancer statistics. CA Cancer J Clin. 64:104–117. 2014. View Article : Google Scholar : PubMed/NCBI
2	McCarthy N: Tumorigenesis: All together now. Nat Rev Cancer. 13:148–149. 2013. View Article : Google Scholar : PubMed/NCBI
3	Madka V and Rao CV: Anti-inflammatory phytochemicals for chemoprevention of colon cancer. Curr Cancer Drug Targets. 13:542–557. 2013. View Article : Google Scholar : PubMed/NCBI
4	Moreno-Jimenez MR, Trujillo-Esquivel F, Gallegos-Corona MA, Reynoso-Camacho R, González-Laredo RF, Gallegos-Infante JA, Rocha-Guzmán NE and Ramos-Gomez M: Antioxidant, anti-inflammatory and anticarcinogenic activities of edible red oak (Quercus spp.) infusions in rat colon carcinogenesis induced by 1,2-dimethylhydrazine. Food Chem Toxicol. 80:144–153. 2015. View Article : Google Scholar : PubMed/NCBI
5	Yu C, Wen XD, Zhang Z, Zhang CF, Wu XH, Martin A, Du W, He TC, Wang CZ and Yuan CS: American ginseng attenuates azoxymethane/dextran sodium sulfate-induced colon carcinogenesis in mice. J Ginseng Res. 39:14–21. 2015. View Article : Google Scholar
6	Saleem M: Lupeol, a novel anti-inflammatory and anti-cancer dietary triterpene. Cancer Lett. 285:109–115. 2009. View Article : Google Scholar : PubMed/NCBI
7	Wang X, Song ZJ, He X, Zhang RQ, Zhang CF, Li F, Wang CZ and Yuan CS: Antitumor and immunomodulatory activity of genkwanin on colorectal cancer in the APC(Min/+) mice. Int Immunopharmacol. 29:701–707. 2015. View Article : Google Scholar : PubMed/NCBI
8	Chinese Pharmacopoeia Commission: Pharmacopoeia of the People's Republic of China (Part 1) China. Medical Science Press; Beijing: 2010
9	Bhadra K and Kumar GS: Therapeutic potential of nucleic acid-binding isoquinoline alkaloids: Binding aspects and implications for drug design. Med Res Rev. 31:821–862. 2011. View Article : Google Scholar
10	Zhang L, Li J, Ma F, Yao S, Li N, Wang J, Wang Y, Wang X and Yao Q: Synthesis and cytotoxicity evaluation of 13-n-alkyl berberine and palmatine analogues as anticancer agents. Molecules. 17:11294–11302. 2012. View Article : Google Scholar : PubMed/NCBI
11	Jung J, Choi JS and Jeong CS: Inhibitory activities of palmatine from coptis chinensis against helicobactor pylori and gastric damage. Toxicol Res. 30:45–48. 2014. View Article : Google Scholar : PubMed/NCBI
12	Wang CZ, Du GJ, Zhang Z, Wen XD, Calway T, Zhen Z, Musch MW, Bissonnette M, Chang EB and Yuan CS: Ginsenoside compound K, not Rb1, possesses potential chemo-preventive activities in human colorectal cancer. Int J Oncol. 40:1970–1976. 2012.PubMed/NCBI
13	Wang CZ, Zhang Z, Huang WH, Du GJ, Wen XD, Calway T, Yu C, Nass R, Zhao J, Du W, et al: Identification of potential anticancer compounds from Oplopanax horridus. Phytomedicine. 20:999–1006. 2013. View Article : Google Scholar : PubMed/NCBI
14	Fichera A, Guo Y, Romero L, Michelassi F and Arenas RB: Quantitation of in vivo gene delivery by restriction enzyme PCR generated polymorphism. J Surg Res. 69:188–192. 1997. View Article : Google Scholar : PubMed/NCBI
15	Mohammed A, Janakiram NB, Li Q, Choi CI, Zhang Y, Steele VE and Rao CV: Chemoprevention of colon and small intestinal tumorigenesis in APC (Min/+) mice by licofelone, a novel dual 5-LOX/COX inhibitor: Potential implications for human colon cancer prevention. Cancer Prev Res (Phila). 4:2015–2026. 2011. View Article : Google Scholar
16	Dougherty U, Mustafi R, Wang Y, Musch MW, Wang CZ, Konda VJ, Kulkarni A, Hart J, Dawson G, Kim KE, et al: American ginseng suppresses Western diet-promoted tumorigenesis in model of inflammation-associated colon cancer: Role of EGFR. BMC Complement Altern Med. 11:1112011. View Article : Google Scholar : PubMed/NCBI
17	Van der Meer R, Lapré JA, Govers MJAP and Kleibeuker JH: Mechanisms of the intestinal effects of dietary fats and milk products on colon carcinogenesis. Cancer Lett. 114:75–83. 1997. View Article : Google Scholar : PubMed/NCBI
18	Jung HA, Yoon NY, Bae HJ, Min BS and Choi JS: Inhibitory activities of the alkaloids from Coptidis Rhizoma against aldose reductase. Arch Pharm Res. 31:1405–1412. 2008. View Article : Google Scholar : PubMed/NCBI
19	Zhang Z, Yu C, Zhang CF, Wu XH, Wen XD, Anderson S, Du W, Huang WH, Li SP, Wang CZ and Yuan CS: Chemopreventive effects of oplopantriol A, a novel compound isolated from Oplopanax horridus, on colorectal cancer. Nutrients. 6:2668–2680. 2014. View Article : Google Scholar : PubMed/NCBI
20	Bin-Hafeez B, Haque R, Parvez S, Pandey S, Sayeed I and Raisuddin S: Immunomodulatory effects of fenugreek (Trigonella foenum graecum L.) extract in mice. Int Immunopharmacol. 3:257–265. 2003. View Article : Google Scholar : PubMed/NCBI
21	Zheng YQ, Wei W, Zhu L and Liu JX: Effects and mechanisms of Paeoniflorin, a bioactive glucoside from paeony root, on adjuvant arthritis in rats. Inflamm Res. 56:182–188. 2007. View Article : Google Scholar : PubMed/NCBI
22	Wang J, Xie Y, Feng Y, Zhang L, Huang X, Shen X and Luo X: (−)-Epigallocatechingallate induces apoptosis in B lymphoma cells via caspase-dependent pathway and Bcl-2 family protein modulation. Int J Oncol. 46:1507–1515. 2015.PubMed/NCBI
23	Grimoud J, Durand H, de Souza S, Monsan P, Ouarné F, Theodorou V and Roques C: In vitro screening of probiotics and synbiotics according to anti-inflammatory and anti-proliferative effects. Int J Food Microbiol. 144:42–50. 2010. View Article : Google Scholar : PubMed/NCBI
24	Garcia Rodriguez LA, Cea-Soriano L, Tacconelli S and Patrignani P: Coxibs: Pharmacology, toxicity and efficacy in cancer clinical trials. Recent Results Cancer Res. 191:67–93. 2013. View Article : Google Scholar
25	Chen S, Qu X, Wan P, Li QW, Wang Z, Guo F, Bai L, Hu Z, Tan W and Li J: Norcantharidin inhibits pre-replicative complexes assembly of HepG2 cells. Am J Chin Med. 41:665–682. 2013. View Article : Google Scholar : PubMed/NCBI
26	Liu S, Wang XJ, Liu Y and Cui YF: PI3K/AKT/mTOR signaling is involved in (−)-epigallocatechin-3-gallate-induced apoptosis of human pancreatic carcinoma cells. Am J Chin Med. 41:629–642. 2013. View Article : Google Scholar
27	Wang CY, Bai XY and Wang CH: Traditional Chinese medicine: A treasured natural resource of anticancer drug research and development. Am J Chin Med. 42:543–559. 2014. View Article : Google Scholar : PubMed/NCBI
28	Yuan A, Chen JJ, Yao PL and Yang PC: The role of interleukin-8 in cancer cells and microenvironment interaction. Front Biosci. 10:853–865. 2005. View Article : Google Scholar
29	De Robertis M, Massi E, Poeta ML, Carotti S, Morini S, Cecchetelli L, Signori E and Fazio VM: The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies. J Carcinog. 10:92011. View Article : Google Scholar : PubMed/NCBI
30	Wen XD, Wang CZ, Yu C, Zhang Z, Calway T, Wang Y, Li P and Yuan CS: Salvia miltiorrhiza (dan shen) significantly ameliorates colon inflammation in dextran sulfate sodium induced colitis. Am J Chin Med. 41:1097–1108. 2013. View Article : Google Scholar : PubMed/NCBI
31	Gu C, Qiao J, Zhu M, Du J, Shang W, Yin W, Wang W, Han M and Lu W: Preliminary evaluation of the interactions of Panax ginseng and Salvia miltiorrhiza Bunge with 5-fluorouracil on pharmacokinetics in rats and pharmacodynamics in human cells. Am J Chin Med. 41:443–458. 2013. View Article : Google Scholar : PubMed/NCBI
32	Park EY, Kim MH, Kim EH, Lee EK, Park IS, Yang DC and Jun HS: Efficacy comparison of Korean ginseng and American ginseng on body temperature and metabolic parameters. Am J Chin Med. 42:173–187. 2014. View Article : Google Scholar : PubMed/NCBI
33	Qi LW, Wang CZ and Yuan CS: Ginsenosides from American ginseng: Chemical and pharmacological diversity. Phytochemistry. 72:689–699. 2011. View Article : Google Scholar : PubMed/NCBI
34	Jacoby RF, Seibert K, Cole CE, Kelloff G and Lubet RA: The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Cancer Res. 60:5040–5044. 2000.PubMed/NCBI
35	Yi J, Ye X, Wang D, He K, Yang Y, Liu X and Li X: Safety evaluation of main alkaloids from Rhizoma Coptidis. J Ethnopharmacol. 145:303–310. 2013. View Article : Google Scholar